Investigación
Infecciones urinarias. Randomized, Double-Blind, Placebo-controlled, Multicenter Phase 3 Study to Assess the Efficacy, Safety And Immunogenicity of Vaccination With ExPECMV in the Prevention of Invasive Extraintestinal Pathogenic Escherichia coli Disease (IED) in Adults Aged 60 Years And Older with a History of Urinary Tract Infection in the Past 2 Years.